Summary
We screened urine for chemical individuality in over 1 million newborn infants, by various chromatographic (thin-layer), chemical and spectrophotometric methods, 12 procedures in all. The programme is part of the Quebec Network of Genetic Medicine. Voluntary urine screening began in 1971 and has evolved with changes in choice of tests and times of sample collection. Urine samples were collected on filter paper at either 5, 14 or 21 days after birth; results were best with the 21-day test. Compliance is over 94% with the latter and over 98% with requests for repeat samples. Screening is centralized in one laboratory; follow-up diagnosis, counselling and management are done at four regional centres. Incidence of phenotypes ranged from 1:4300 live births (for expressed cystinuria alleles) to 1 per million (for hyperargininaemia). Over 20 inherited Mendelian disorders were identified. 30 patients required aggressive medical management. We show how this programme can be used for neuroblastoma screening.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Auray-Blais, C., Giguère, R., Draper, P., Shapcott, D. and Lemieux, B. Simple and rapid system for screening and identification of reducing sugars in urine.Clin. Biochem. 11 (1978) 235–237
Auray-Blais, C., Giguère, R. and Lemieux, B.Histidinemia in a Newborn Urine Screening Program, Excerpta Medica/Elsevèr, Princeton, 1982a, pp. 304–305
Auray-Blais, C., Giguère, R. and Lemieux, B. Thin-layer chromatographic technique in a newborn urinary screening program, Excerpta Medica/Elsevier, Princeton, 1982b, pp. 418–419
Auray-Blais, C., Giguère, R., Paradis, D. and Lemieux, B. Rapid thin-layer chromatography method for the detection of urinary methylmalonic acid.Clin. Biochem. 12 (1979) 43–45
Chasson, A. L., Grady, H. J. and Stanley, M. A. Determination of creatinine by means of automatic chemical analysis.Am. J. Clin. Pathol. 35 (1961) 83–88
Clow, C. L., Reade, T. R., and Scriver, C. R. Outcome of early and long-term management of classical Maple Syrup Urine Disease.Pediatrics 68 (1981) 856–862
Coulombe, J. T., Shih, V. E. and Levy, H. L. Massachusetts metabolic disorders screening program. II. Methylmalonic aciduria.Pediatrics 67 (1981) 26–31
Dagenais, D. L., Courville, L. and Dagenais, M. G. A cost-benefit analysis of the Quebec Network of Genetic Medicine.Soc. Sci. Med. 20 (1985) 601–607
Garrod, A. E.Inborn Errors of Metabolism, Froude, Hodder and Stoughton, London, 1909
Giguère, R., Auray-Blais, C., Draper, P. and Lemieux, B. Diet and medications giving positive ninhydrin reactions on TLC in a newborn urinary screening program.Clin. Biochem. 13 (1980) 103–105
Giorghio, A. J. and Lubby, A. L. A rapid screening test for the detection of congenital methylmalonic aciduria in infancy.Am. J. Clin. Pathol. 52 (1969) 374–379
Katsuki, H., Yoshida, T., Tanegashima, C. and Tanaka, S. Improved direct method for determination of keto acids by 2,4-dinitrophenylhydrazine.Anal. Biochem. 43 (1971) 349–356
Laberge, C., Scriver, C. R., Clow, C. L. and Dufour, D. Le réseau de médecine génétique du Québec: un programme intégré de diagnostic, conseil et traitement des maladies métabolique héréditaires.Union Med. Can. 104 (1975) 428–432
Lasley, L. and Scriver, C. R. Ontogeny of amino acid reabsorption in human kidney. Evidence from the homozygous infant with familial renal iminoglycinuria for multiple proline and glycine systems.Pediatr. Res. 13 (1979) 65–70
Lemieux, B., Auray-Blais, C. and Giguère, R. Comparison between amino acids and orotic acid analysis in the detection of urea cycle disorders in the Quebec Urinary Screening Program. In: Lowenthal, A., Mori, A. and Marescau, B. (eds.)Urea Cycle Disease, Plenum, New York, 1983, pp. 321–329
Lemieux, B., Auray-Blais, C., Giguère, R. and Shapcott, D. Prolidase deficiency: detection of cases by a newborn urinary screening program.J. Inher. Metab. Dis. 7, Supp. 2 (1984) 145–146
Lemieux, B., Gervais, M. H. and Shapcott, D. Dépistage systémique des maladies métaboliques héréditaires chez le nouveau-né: programme urinaire.La Vie Médicale au Canada Français. 3 (1974) 321–329
Levy, H. L., Coulombe, J. T. and Benjamin, R. Massachusetts Metabolic Disorders Screening Program. III. Sarcosinemia.Pediatrics 74 (1984) 509–513
Levy, H. L., Coulombe, J. T. and Shih, V. E. Newborn urine screening. In: Bickel, H., Guthrie, R. and Hammersen, G. (eds.)Neonatal Screening for Inborn Errors of Metabolism, Springer-Verlag, Berlin, Heidelberg, New York, 1980, pp. 89–103
Levy, H. L., Madigan, P. M. and Shih, V. E. Massachusetts Metabolic Disorders Screening Program. I. Technics and results in urine screening.Pediatrics 49 (1972) 825–836
McInnes, R., Lamm, P., Clow, C. L. and Scriver, C. R. A filter paper sampling method for the uric acid: creatinine ratio in urine.Pediatrics 49 (1971) 80–84
Mitchell, G. A., Watkins, D., Melançon, S. B., Rosenblatt, D. S., Geoffroy, G., Orguin, J., Homsey, M. B. and Dallaire, L. Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria.J. Pediatr. 108 (1986) 410–415
National Academy of Sciences (National Res. Council).Genetic Screening. Programs, Principles and Research. Washington, DC, 1975
Nishi, H. H. Determination of uric acid: an adaptation of the Archibald method on the autoanalyzer.Clin. Chem. 13 (1967) 12–18
Paradis, D., Giguère, R., Auray-Blais, C., Draper, P. and Lemieux, B. An automated method for the detection of orotic acid in the urine of children being screened for metabolic disorders.Clin. Biochem. 13 (1980) 160–168
Qureshi, I. A., Letarte, J., Ouellet, R., Larochelle, J. and Lemieux, B. A new French-Canadian family affected by hyperargininemia.J. Inher. Metab. Dis. 6 (1983) 179–182
Rosenblatt, D. S., Laframboise, R., Pichette, J., Langevin, P., Cooper, B. A. and Costa, T. New disorder of vitamin B12 metabolism (cobalamin F) presenting as methylmalonic aciduria.Pediatrics 78 (1986) 51–54
Scriver, C. R., Clow, C. L., Reade, T. M., Goodyer, P., Auray-Blais, C., Giguère, R. and Lemieux, B. Ontogeny modifies manifestations of cystinuria genes: implications for counselling.J. Pediatr. 106 (1985) 411–416
Scriver, C. R., Gregory, D., Bernstein, M., Clow, C. L., Weisdorf, T., Dougherty, G. E., Auray-Blais, C., Giguère, R. and Lemieux, B. Chemical screening of urine for neuroblastoma case finding in infancy. A feasibility study in Quebec.Can. Med. Assoc. J. 136 (1987) 952–956
Scriver, C. R., Laberge, C., Clow, C. L. and Fraser, F. C. Genetics and medicine: an evolving relationship.Science 20 (1978) 946–952
Scriver, C. R. and Levy, H. L. Histidinemia. I. Reconciling retrospective and prospective findings.J. Inher. Metab. Dis. 6 (1983) 51–53
Scriver, C. R., Mahon, B., Levy, H. L., Clow, C. L., Reade, T., Kronick, J., Lemieux, B. and Laberge, C. The Hartnup phenotype: mendelian transport disorder, multifactorial disease.Am. J. Hum. Genet. 40 (1987) 401–412
Shapcott, D. and Lemieux, B. A semi-automatic device for multiple sample application to thin-layer chromatography plates.J. Chromatog. 70 (1972) 174–178
Smith, I.Chromatographic and Electrophoretic Techniques, Vol. 1.Chromatography, 3rd edn. W. Heinemann Ltd., 1969, pp. 104–169
Tuchman, M., Auray-Blais, C., Rammaraine, M. L. R., Rosenberg, M. S., Neglia, J., Giguère, R., Krivit, W. and Lemieux, B. Determination of homovanillic and vanillylmandelic acids from dried filter paper samples: assessment of potential methods for neuroblastoma screening.Clin. Biochem. 20 (1987) 173–177
Wells, M. G. A simple rapid method for the determination of α-amino nitrogen in urine.Clin. Chim. Acta 25 (1969) 27–29
Wilcken, B., Smith, A. and Brown, D. A. Urine screening for aminoacidopathies: is it beneficial?J. Pediatr. 97 (1980) 492–497
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lemieux, B., Auray-Blais, C., Giguère, R. et al. Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine. J Inherit Metab Dis 11, 45–55 (1988). https://doi.org/10.1007/BF01800056
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01800056